S9. Proffered paper: Identification of novel immune checkpoints as targets for cancer immunotherapy

Detalles Bibliográficos
Autores principales: Cojocaru, G, Rotman, G, Levy, O, Toporik, A, Dassa, L, Vaknin, I, Sameah-Greenwald, S, Barbiro, I, Neria, E, Levine, Z
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Invited Speaker Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072160/
http://dx.doi.org/10.1186/2051-1426-2-S2-I5
_version_ 1782322915380822016
author Cojocaru, G
Rotman, G
Levy, O
Toporik, A
Dassa, L
Vaknin, I
Sameah-Greenwald, S
Barbiro, I
Neria, E
Levine, Z
author_facet Cojocaru, G
Rotman, G
Levy, O
Toporik, A
Dassa, L
Vaknin, I
Sameah-Greenwald, S
Barbiro, I
Neria, E
Levine, Z
author_sort Cojocaru, G
collection PubMed
description
format Online
Article
Text
id pubmed-4072160
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40721602014-06-27 S9. Proffered paper: Identification of novel immune checkpoints as targets for cancer immunotherapy Cojocaru, G Rotman, G Levy, O Toporik, A Dassa, L Vaknin, I Sameah-Greenwald, S Barbiro, I Neria, E Levine, Z J Immunother Cancer Invited Speaker Presentation BioMed Central 2014-03-12 /pmc/articles/PMC4072160/ http://dx.doi.org/10.1186/2051-1426-2-S2-I5 Text en Copyright © 2014 Cojocaru et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Invited Speaker Presentation
Cojocaru, G
Rotman, G
Levy, O
Toporik, A
Dassa, L
Vaknin, I
Sameah-Greenwald, S
Barbiro, I
Neria, E
Levine, Z
S9. Proffered paper: Identification of novel immune checkpoints as targets for cancer immunotherapy
title S9. Proffered paper: Identification of novel immune checkpoints as targets for cancer immunotherapy
title_full S9. Proffered paper: Identification of novel immune checkpoints as targets for cancer immunotherapy
title_fullStr S9. Proffered paper: Identification of novel immune checkpoints as targets for cancer immunotherapy
title_full_unstemmed S9. Proffered paper: Identification of novel immune checkpoints as targets for cancer immunotherapy
title_short S9. Proffered paper: Identification of novel immune checkpoints as targets for cancer immunotherapy
title_sort s9. proffered paper: identification of novel immune checkpoints as targets for cancer immunotherapy
topic Invited Speaker Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072160/
http://dx.doi.org/10.1186/2051-1426-2-S2-I5
work_keys_str_mv AT cojocarug s9profferedpaperidentificationofnovelimmunecheckpointsastargetsforcancerimmunotherapy
AT rotmang s9profferedpaperidentificationofnovelimmunecheckpointsastargetsforcancerimmunotherapy
AT levyo s9profferedpaperidentificationofnovelimmunecheckpointsastargetsforcancerimmunotherapy
AT toporika s9profferedpaperidentificationofnovelimmunecheckpointsastargetsforcancerimmunotherapy
AT dassal s9profferedpaperidentificationofnovelimmunecheckpointsastargetsforcancerimmunotherapy
AT vaknini s9profferedpaperidentificationofnovelimmunecheckpointsastargetsforcancerimmunotherapy
AT sameahgreenwalds s9profferedpaperidentificationofnovelimmunecheckpointsastargetsforcancerimmunotherapy
AT barbiroi s9profferedpaperidentificationofnovelimmunecheckpointsastargetsforcancerimmunotherapy
AT neriae s9profferedpaperidentificationofnovelimmunecheckpointsastargetsforcancerimmunotherapy
AT levinez s9profferedpaperidentificationofnovelimmunecheckpointsastargetsforcancerimmunotherapy

Ejemplares similares